We need phase II and phase III in order to receive emergency use authorization. We went to Health Canada seeking a combined phase II-phase III trial, and Health Canada felt that it would be more appropriate for us to split those trials into discrete trials. That has the effect of extending the program by about three months.
We were hoping to have an approved vaccine in October or November. I would expect that our vaccine will now be approved in January or February 2022.